PACS Group, Inc. (PACS)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $7.67B
Last updated: Nov 17, 2026 at 11:06 AM ET
PACS Group, Inc. (PACS) Financials: Revenue, Profit and Cash Flow
PACS Group reported revenue of $5.29B for the fiscal year ended Dec 31, 2025, up 29.3% from the year before. That year, net income was $191.46M with a net margin of 3.6%, operating cash flow was $404.22M and free cash flow was $155.07M. The quarter ended Sep 30, 2026 had revenue of $1.50B and net income of $60.81M.
Revenue and Margins
The operating margin was 5.9% in the fiscal year ended Dec 2025.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $5.29B | +29.3% | 21.9% | 5.9% | 3.6% |
| Dec 2024 | $4.09B | +31.4% | 19.4% | 3.0% | 1.4% |
| Dec 2023 | $3.11B | +28.5% | 21.3% | 6.7% | 3.6% |
| Dec 2022 | $2.42B | +107.6% | 23.1% | 9.5% | 6.2% |
| Dec 2021 | $1.17B | N/A | 16.1% | 7.1% | 4.1% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 246.0% from the year before. In the quarter ended Sep 2026, net income rose 16.2% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | $5.29B | $4.09B | $3.11B | $2.42B | $1.17B |
| Cost of revenue | $4.13B | $3.30B | $2.45B | $1.86B | $979.22M |
| Gross profit | $1.16B | $792.64M | $663.78M | $560.68M | $187.35M |
| Operating income | $309.60M | $123.07M | $207.77M | $229.36M | $83.36M |
| Net income | $191.46M | $55.34M | $112.88M | $150.50M | $47.95M |
| EBITDA | $371.62M | $189.82M | $238.94M | $256.10M | $93.86M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.50B | $1.43B | $1.42B | $1.36B | $1.34B | $1.31B | $1.28B | $1.21B | $1.03B | $935.71M | $919.84M | $853.20M |
| Gross profit | $356.43M | $338.46M | $345.96M | $319.21M | $298.31M | $288.36M | $253.36M | $258.54M | $176.71M | $173.56M | $183.84M | $173.56M |
| Operating income | $99.72M | $109.33M | $120.03M | $94.69M | $86.27M | $80.50M | $48.14M | $71.98M | $22.96M | -$37.18M | $65.31M | $62.54M |
| Net income | $60.81M | $76.35M | $80.67M | $59.78M | $52.33M | $50.97M | $28.38M | $36.19M | $16.21M | -$31.88M | $34.82M | $34.14M |
Balance Sheet
As of Dec 2025, total debt of $349.27M exceeded cash and equivalents by $152.25M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total assets | $5.58B | $5.24B | $3.51B | $2.46B | N/A |
| Current assets | $1.07B | $938.26M | $722.15M | $511.16M | N/A |
| Cash and equivalents | $197.02M | $157.67M | $73.42M | $66.12M | N/A |
| Total liabilities | $4.63B | $4.53B | $3.41B | $2.39B | N/A |
| Short-term debt | $4.46M | $156.85M | $16.82M | $182.43M | N/A |
| Long-term debt | $344.80M | $250.98M | $715.71M | $438.34M | N/A |
| Shareholder equity | $946.77M | $709.55M | $96.13M | $63.65M | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.92B | $5.66B | $5.66B | $5.58B | $5.63B | $5.50B | $5.49B | $5.24B | $4.52B | $3.93B | $3.86B | $3.51B |
| Total liabilities | $4.70B | $4.54B | $4.62B | $4.63B | $4.75B | $4.69B | $4.74B | $4.53B | $3.85B | $3.39B | $3.74B | $3.41B |
| Cash and equivalents | $115.28M | $164.45M | $247.98M | $197.02M | $355.67M | $294.17M | $287.51M | $157.67M | $49.52M | $73.37M | $81.21M | $73.42M |
| Shareholder equity | $1.21B | $1.11B | $1.04B | $946.77M | $871.32M | $806.84M | $750.23M | $709.55M | $660.05M | $536.84M | $113.67M | $96.13M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 38.4% of operating cash flow. Dividends came to 0.2% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $404.22M | $367.34M | $63.70M | $92.61M | $57.60M |
| Capital expenditures | $249.16M | $349.81M | $172.81M | $78.24M | $124.09M |
| Free cash flow | $155.07M | $17.53M | -$109.11M | $14.38M | -$66.48M |
| Dividends paid | $377.00K | $33.72M | $80.39M | $60.28M | $53.80M |
| Investing cash flow | -$264.02M | -$442.68M | -$172.79M | -$75.32M | -$218.60M |
| Financing cash flow | -$68.99M | $117.48M | $129.59M | $12.35M | $182.05M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $211.24M | $135.51M | $236.34M | -$3.39M | $204.80M | $52.57M | $150.24M | $64.59M | $209.15M | $34.74M | $58.75M | -$9.70M |
| Capital expenditures | $218.02M | $130.81M | $108.35M | $114.26M | $98.36M | $18.82M | $17.72M | $83.17M | $65.89M | $111.48M | $89.26M | $57.82M |
| Free cash flow | -$6.79M | $4.70M | $127.99M | -$117.65M | $106.44M | $33.76M | $132.53M | -$18.58M | $143.26M | -$76.75M | -$30.51M | -$67.52M |
Frequently Asked Questions About PACS
What is PACS Group's annual revenue?
PACS Group reported revenue of $5.29B for the fiscal year ended Dec 31, 2025.
How fast is PACS Group's revenue growing?
Revenue was up 29.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 29.7%.
Is PACS Group profitable?
Yes. PACS Group reported net income of $191.46M for the fiscal year ended Dec 31, 2025, with a net margin of 3.6%.
How much free cash flow does PACS generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $404.22M minus capital expenditures of $249.16M produced free cash flow of $155.07M.
How much debt does PACS Group have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $344.80M, short-term debt of $4.46M and cash and equivalents of $197.02M.
PACS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors